Drug Trial Radar · NCT01473381
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Aug 8, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,162
Actual
Start
Dec 2011
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Forest LaboratoriesAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Nov 17, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.
Conditions
- Major Depressive Disorder
Interventions
VilazodoneDrug
Vilazodone was supplied as film-coated tablets.
Placebo to citalopramDrug
Placebo to citalopram was supplied as a capsule.
Placebo to vilazodoneDrug
Placebo to vilazodone was supplied as film-coated tablets.
CitalopramDrug
Citalopram was supplied as encapsulated tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score at Week 10Time frame: Baseline to Week 10
Locations
54 sites in 1 country. Site status is shown where the registry gives one.
Forest Investigative Site 036
Birmingham, Alabama
Forest Investigative Site 016
Dothan, Alabama
Forest Investigative Site 033
Scottsdale, Arizona
Forest Investigative Site 027
Fayetteville, Arkansas
Forest Investigative Site 029
Cerritos, California
Forest Investigative Site 002
Costa Mesa, California
Forest Investigative Site 019
Murrieta, California
Forest Investigative Site 025
Oceanside, California
Forest Investigative Site 043
Orange, California
Forest Investigative Site 003
Redlands, California
Forest Investigative Site 046
Sherman Oaks, California
Forest Investigative Site 057
Upland, California
Forest Investigative Site 034
Cromwell, Connecticut
Forest Investigative Site 038
Fort Myers, Florida
Forest Investigative Site 018
Gainsville, Florida
Forest Investigative Site 055
Hallandale, Florida
Forest Investigative Site 063
Jacksonville, Florida
Forest Investigative Site 035
Miami, Florida
Forest Investigative Site 030
Orlando, Florida
Forest Investigative Site 062
Orlando, Florida
Forest Investigative Site 045
Pembroke Pines, Florida
Forest Investigative Site 051
Tampa, Florida
Forest Investigative Site 032
West Palm Beach, Florida
Forest Investigative Site 022
Winter Park, Florida
Forest Investigative Site 060
Atlanta, Georgia
Forest Investigative Site 037
Chicago, Illinois
Forest Investigative Site 050
Chicago, Illinois
Forest Investigative Site 040
Indianapolis, Indiana
Forest Investigative Site 012
Lafayette, Indiana
Forest Investigative Site 053
Prairie Village, Kansas
Forest Investigative Site 020
Baltimore, Maryland
Forest Investigative Site 031
Boston, Massachusetts
Forest Investigative Site 061
Las Vegas, Nevada
Forest Investigative Site 024
Willingboro, New Jersey
Forest Investigative Site 010
Albuquerque, New Mexico
Forest Investigative Site 011
Albuquerque, New Mexico
Forest Investigative Site 004
Brooklyn, New York
Forest Investigative Site 007
Cedarhurst, New York
Forest Investigative Site 058
New York, New York
Forest Investigative Site 047
New York, New York
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.